Similar content being viewed by others Background Metabolic syndrome (MetS) is defined as a low-intensity chronic proinflammatory condition in which abnormal metabolic factors increase the risk of developing diabetes, cardiovascular disease, and neurodegenerative disease, with diverse harmful effects on an individual's health and quality of life [1, 2]
These administrative barriers can delay treatment initiation and may preferentially restrict access to patients with the most severe disease
Growing Market and Industry Trends Skincare has been redefined by the beauty-from-within movement, which encourages customers to use dietary supplements in addition to topical beauty regimens
A provider who promises specific weight loss numbers is overpromising
Complete avoidance is not required for most patients based on current evidence
If validated, integration of microbial profiling with incretin-based therapy may contribute to more individualized approaches for obesity and T2D management